Apabetalone Reduces Fibrotic Inflammatory and Calcific Factors in Renal Cells and Patient Plasma: FR-PO1052 by Gilham, Dean, Wasiak, Sylwia, Rakai, Brooke D., Fu, Li, Tsujikawa, Laura, Sarsons, Chris, Carestia, Agostina, Lebioda, Kenneth E., Johansson, Jan O., Sweeney, Michael, Kalantar-Zadeh, Kamyar, Kulikowski, Ewelina

Get full text

Apabetalone, an Inhibitor of BET Proteins, Downregulates Alkaline Phosphatase and Improves Cardiovascular Risk: PO0648 by Gilham, Dean, Tsujikawa, Laura, Fu, Li, Wasiak, Sylwia, Halliday, Christopher, Sarsons, Chris, Ho, Phoebe S., Stotz, Stephanie, Rakai, Brooke D., Lebioda, Kenneth E., Jahagirdar, Ravi, Sweeney, Michael, Johansson, Jan O., Wong, Norman C., Kalantar-Zadeh, Kamyar, Haarhaus, Mathias, Kulikowski, Ewelina

Get full text

Apabetalone Mediated Epigenetic Modulation is Associated with Favorable Kidney Function and Alkaline Phosphatase Profile in Patients with Chronic Kidney Disease by Kulikowski, Ewelina, Halliday, Christopher, Johansson, Jan, Sweeney, Mike, Lebioda, Kenneth, Wong, Norman, Haarhaus, Mathias, Brandenburg, Vincent, Beddhu, Srinivasan, Tonelli, Marcello, Zoccali, Carmine, Kalantar-Zadeh, Kamyar

Get full text

Apabetalone lowers serum alkaline phosphatase and improves cardiovascular risk in patients with cardiovascular disease by Haarhaus, Mathias, Ray, Kausik K., Nicholls, Stephen J., Schwartz, Gregory G., Kulikowski, Ewelina, Johansson, Jan O., Sweeney, Michael, Halliday, Christopher, Lebioda, Kenneth, Wong, Norman, Brandenburg, Vincent, Beddhu, Srinivasan, Tonelli, Marcello, Zoccali, Carmine, Kalantar-Zadeh, Kamyar

Get full text